Vibha Jawa

Company: Bristol Myers Squibb
Job title: Executive Director
Seminars:
Have The Speakers Answer Your Questions 3:30 pm
day: Day Two
Development of an Immunogenicity Risk Assessment Strategy to Drive Bioanalysis & Clinical Immune Monitoring for Viral Gene therapies 1:00 pm
Risk assessment of gene therapy based biologics: understanding risks due to capsid serotypes, transgene, site of administration, standard of care treatments and dose, product and host related factors Bioanalytical assays for PK and immunogenicity and clinical and nonclinical studies Assay formats and technical challengesRead more
day: Day Two